Effect of glycosoaminoglycans on the clinical course of diabetic nephropathy at the stage of microalbuminuria in patients with type 2 diabetes mellitus
Aim. To evaluate clinical efficiency of sulodexide (glycosoaminoglycan) for the treatment of patients with type 2 diabetes mellitus (DM2) and diabeticnephropathy (DN) at the stage of microalbuminuria (MAU). Materials and methods. A total of 30 patients with DM2 and MAU were examined 15 of whom wer...
Main Authors: | Iya Vladimirovna Semenova, Lyudmila Alexandrovna Chugunova, Alexander Viktorovich Il'in, Anna Petrovna Knyazeva, Lidia Dmitrievna Chirkova, Marina Vladimirovna Shestakova, Ivan Ivanovich Dedov |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2010-06-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://www.dia-endojournals.ru/jour/article/view/5671 |
Similar Items
-
The Effects of Low Molecular Weight Heparin on Microalbuminuria in Patients with Type II Diabetes Mellitus
by: Meltem Sertbaş, et al.
Published: (2020-06-01) -
Diabetes Self-Management Education in South Auckland, New Zealand, 2007-2008
by: Martha Silva, PhD, et al.
Published: (2011-03-01) -
Microalbuminuria in Type 2 Diabetic Patient with Hypertension
by: Peera Buranakitjaroen, et al.
Published: (2006-11-01) -
A story of microalbuminuria and diabetic nephropathy
by: Bijan Roshan, et al.
Published: (2013-10-01) -
Frequency of Hyperlipidemia in Type 2 Diabetes Mellitus Patients with Microalbuminuria
by: Maeda Jabeen, et al.
Published: (2024-04-01)